Guest
Guest
May 17, 2026
11:20 PM
|
For formulation scientists and CMC teams, encapsulating small molecule therapeutics presents a unique set of challenges that differ fundamentally from the entrapment of large macromolecules like mRNA or proteins. Formulators driving IND-enabling studies frequently encounter critical bottlenecks: capture-volume limited encapsulation, premature payload leakage in serum environments, and the complex balancing of variables—such as lipid ratios, internal salt systems, and loading temperatures—to achieve batch-to-batch reproducibility during scale-up.
|
